Neurology Edition: Top Headlines for Week of November 7, 2022

In this edition, we bring you more news and Healio-exclusive interviews from the American Neurological Association Annual Meeting.

Read the full coverage here:

Diversity key to understanding genetics of neurodegenerative disease

Assessing chemical exposures key to understanding neuro diseases and disorders

VIDEO: Neurological complications can spur from certain infectious diseases

Age, specific pathology tied to shorter symptom duration in rapidly progressive dementia

Cognition in persons with epilepsy dependent on type, therapy model

References:

Asghar F et al. Cognition in persons with epilepsy: Differences based on disease type and therapy. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Cory-Slechta DA. Chemical exposures: The ignored environmental risk factors for neurodegenerative diseases and neurodevelopmental disorders. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Guerreiro R. The genetics of neurodegenerative diseases: from rare populations to common variants. Presented at: American Neurological Association annual meeting; Oct. 23-25, 2022; Chicago.

Lazar E, et al. Dissecting the neuropathological contributors to rapidly progressive dementia. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Saylor D, et al. A string of pearls: Key considerations in the care of neurological infections. Presented at: American Neurological Association annual meeting; Oct. 23-25, 2022; Chicago.